Literature DB >> 24446190

Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: adaptation to hypoxia or prevention from oxidative stress?

Annamaria D'Aprile1, Rosella Scrima, Giovanni Quarato, Tiziana Tataranni, Franca Falzetti, Mauro Di Ianni, Marica Gemei, Luigi Del Vecchio, Claudia Piccoli, Nazzareno Capitanio.   

Abstract

Oxidative metabolism and redox signaling prove to play a decisional role in controlling adult hematopoietic stem/progenitor cells (HSPCs) biology. However, HSPCs reside in a hypoxic bone marrow microenvironment raising the question of how oxygen metabolism might be ensued. In this study, we provide for the first time novel functional and molecular evidences that human HSPCs express myoglobin (Mb) at level comparable with that of a muscle-derived cell line. Optical spectroscopy and oxymetry enabled to estimate an O2-sensitive heme-containing protein content of approximately 180 ng globin per 10(6) HSPC and a P50 of approximately 3 µM O2. Noticeably, expression of Mb mainly occurs through a HIF-1-induced alternative transcript (Mb-V/Mb-N = 35 ± 15, p < .01). A search for other Mb-related globins unveiled significant expression of neuroglobin (Ngb) but not of cytoglobin. Confocal microscopy immune detection of Mb in HSPCs strikingly revealed nuclear localization in cell subsets expressing high level of CD34 (nuclear/cytoplasmic Mb ratios 1.40 ± 0.02 vs. 0.85 ± 0.05, p < .01) whereas Ngb was homogeneously distributed in all the HSPC population. Dual-color fluorescence flow cytometry indicated that while the Mb content was homogeneously distributed in all the HSPC subsets that of Ngb was twofold higher in more immature HSPC. Moreover, we show that HSPCs exhibit a hypoxic nitrite reductase activity releasing NO consistent with described noncanonical functions of globins. Our finding extends the notion that Mb and Ngb can be expressed in nonmuscle and non-neural contexts, respectively, and is suggestive of a differential role of Mb in HSPC in controlling oxidative metabolism at different stages of commitment. © AlphaMed Press.

Entities:  

Keywords:  Hematopoietic stem/progenitor cells; Hypoxic adaptation; Myoglobin; Neuroglobin; Redox signaling

Mesh:

Substances:

Year:  2014        PMID: 24446190     DOI: 10.1002/stem.1646

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Myoglobin expression by alternative transcript in different mesenchymal stem cells compartments.

Authors:  Rosella Scrima; Francesca Agriesti; Consiglia Pacelli; Claudia Piccoli; Pietro Pucci; Angela Amoresano; Olga Cela; Luigi Nappi; Tiziana Tataranni; Giorgio Mori; Pietro Formisano; Nazzareno Capitanio
Journal:  Stem Cell Res Ther       Date:  2022-05-21       Impact factor: 8.079

Review 2.  Neuroglobin Expression in the Brain: a Story of Tissue Homeostasis Preservation.

Authors:  Zoë P Van Acker; Evi Luyckx; Sylvia Dewilde
Journal:  Mol Neurobiol       Date:  2018-07-10       Impact factor: 5.590

3.  Impact of A90P, F106L and H64V mutations on neuroglobin stability and ligand binding kinetics.

Authors:  E André; V Derrien; P Sebban; N Assrir; E Lescop; S Bernad
Journal:  J Biol Inorg Chem       Date:  2018-10-25       Impact factor: 3.358

4.  Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers.

Authors:  Marwa E Elsherbiny; Mohammed Shaaban; Rana El-Tohamy; Islam E Elkholi; Olfat Ali Hammam; Mona Magdy; Joan Allalunis-Turner; Marwan Emara
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

5.  More than hemoglobin - the unexpected diversity of globins in vertebrate red blood cells.

Authors:  Miriam Götting; Mikko Nikinmaa
Journal:  Physiol Rep       Date:  2015-02-03

6.  The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.

Authors:  Anne Bicker; Alexandra M Brahmer; Sebastian Meller; Glen Kristiansen; Thomas A Gorr; Thomas Hankeln
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.